Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 37349

Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.
The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.
One of the primary drivers for the market growth is the escalating patient population with iodine deficiency. Iodine deficiency is predominant around the globe when compared with the large consumers of iodine and is particularly seen in pregnant women and young children. Iodine is present in the body in minute amounts, mainly in the thyroid gland and has a significant role to play in the thyroid synthesis.  It has been observed that over two billion individuals have insufficient iodine intake, among which South Asia and sub-Saharan Africa are majorly affected. The introduction of various remedies for the treatment of this deficiency will boost market growth in the coming years.
In 2018, the global Thyroid Gland Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Thyroid Gland Disorder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thyroid Gland Disorder Treatment development in United States, Europe and China.

The key players covered in this study
Abbott
bioMérieux
Danaher
DiaSorin
Siemens Healthineers
...

Market segment by Type, the product can be split into
Hyperthyroidism
Hypothyroidism
Others

Market segment by Application, split into
Men
Women

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Thyroid Gland Disorder Treatment status, future forecast, growth opportunity, key market and key players.
To present the Thyroid Gland Disorder Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Thyroid Gland Disorder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thyroid Gland Disorder Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Hyperthyroidism
1.4.3 Hypothyroidism
1.4.4 Others
1.5 Market by Application
1.5.1 Global Thyroid Gland Disorder Treatment Market Share by Application (2014-2025)
1.5.2 Men
1.5.3 Women
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Thyroid Gland Disorder Treatment Market Size
2.2 Thyroid Gland Disorder Treatment Growth Trends by Regions
2.2.1 Thyroid Gland Disorder Treatment Market Size by Regions (2014-2025)
2.2.2 Thyroid Gland Disorder Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Thyroid Gland Disorder Treatment Market Size by Manufacturers
3.1.1 Global Thyroid Gland Disorder Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Thyroid Gland Disorder Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Thyroid Gland Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Thyroid Gland Disorder Treatment Key Players Head office and Area Served
3.3 Key Players Thyroid Gland Disorder Treatment Product/Solution/Service
3.4 Date of Enter into Thyroid Gland Disorder Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Thyroid Gland Disorder Treatment Market Size by Type (2014-2019)
4.2 Global Thyroid Gland Disorder Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Thyroid Gland Disorder Treatment Market Size (2014-2019)
5.2 Thyroid Gland Disorder Treatment Key Players in United States
5.3 United States Thyroid Gland Disorder Treatment Market Size by Type
5.4 United States Thyroid Gland Disorder Treatment Market Size by Application

6 Europe
6.1 Europe Thyroid Gland Disorder Treatment Market Size (2014-2019)
6.2 Thyroid Gland Disorder Treatment Key Players in Europe
6.3 Europe Thyroid Gland Disorder Treatment Market Size by Type
6.4 Europe Thyroid Gland Disorder Treatment Market Size by Application

7 China
7.1 China Thyroid Gland Disorder Treatment Market Size (2014-2019)
7.2 Thyroid Gland Disorder Treatment Key Players in China
7.3 China Thyroid Gland Disorder Treatment Market Size by Type
7.4 China Thyroid Gland Disorder Treatment Market Size by Application

8 Japan
8.1 Japan Thyroid Gland Disorder Treatment Market Size (2014-2019)
8.2 Thyroid Gland Disorder Treatment Key Players in Japan
8.3 Japan Thyroid Gland Disorder Treatment Market Size by Type
8.4 Japan Thyroid Gland Disorder Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Thyroid Gland Disorder Treatment Market Size (2014-2019)
9.2 Thyroid Gland Disorder Treatment Key Players in Southeast Asia
9.3 Southeast Asia Thyroid Gland Disorder Treatment Market Size by Type
9.4 Southeast Asia Thyroid Gland Disorder Treatment Market Size by Application

10 India
10.1 India Thyroid Gland Disorder Treatment Market Size (2014-2019)
10.2 Thyroid Gland Disorder Treatment Key Players in India
10.3 India Thyroid Gland Disorder Treatment Market Size by Type
10.4 India Thyroid Gland Disorder Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Thyroid Gland Disorder Treatment Market Size (2014-2019)
11.2 Thyroid Gland Disorder Treatment Key Players in Central & South America
11.3 Central & South America Thyroid Gland Disorder Treatment Market Size by Type
11.4 Central & South America Thyroid Gland Disorder Treatment Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Thyroid Gland Disorder Treatment Introduction
12.1.4 Abbott Revenue in Thyroid Gland Disorder Treatment Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 bioMérieux
12.2.1 bioMérieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Thyroid Gland Disorder Treatment Introduction
12.2.4 bioMérieux Revenue in Thyroid Gland Disorder Treatment Business (2014-2019)
12.2.5 bioMérieux Recent Development
12.3 Danaher
12.3.1 Danaher Company Details
12.3.2 Company Description and Business Overview
12.3.3 Thyroid Gland Disorder Treatment Introduction
12.3.4 Danaher Revenue in Thyroid Gland Disorder Treatment Business (2014-2019)
12.3.5 Danaher Recent Development
12.4 DiaSorin
12.4.1 DiaSorin Company Details
12.4.2 Company Description and Business Overview
12.4.3 Thyroid Gland Disorder Treatment Introduction
12.4.4 DiaSorin Revenue in Thyroid Gland Disorder Treatment Business (2014-2019)
12.4.5 DiaSorin Recent Development
12.5 Siemens Healthineers
12.5.1 Siemens Healthineers Company Details
12.5.2 Company Description and Business Overview
12.5.3 Thyroid Gland Disorder Treatment Introduction
12.5.4 Siemens Healthineers Revenue in Thyroid Gland Disorder Treatment Business (2014-2019)
12.5.5 Siemens Healthineers Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details